Copyright Reports & Markets. All rights reserved.

Global Prostate Specific Antigen Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 Prostate Specific Antigen Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Prostate Specific Antigen Market Size Growth Rate by Product
      • 1.4.2 G-115
      • 1.4.3 INO-5150
      • 1.4.4 ADXS-PSA
      • 1.4.5 AEZS-120
      • 1.4.6 Others
    • 1.5 Market by End User
      • 1.5.1 Global Prostate Specific Antigen Market Size Growth Rate by End User
      • 1.5.2 Prostate Cancer
      • 1.5.3 Metastatic Hormone Refractory Prostate Cancer
      • 1.5.4 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Prostate Specific Antigen Market Size
      • 2.1.1 Global Prostate Specific Antigen Revenue 2014-2025
      • 2.1.2 Global Prostate Specific Antigen Sales 2014-2025
    • 2.2 Prostate Specific Antigen Growth Rate by Regions
      • 2.2.1 Global Prostate Specific Antigen Sales by Regions
      • 2.2.2 Global Prostate Specific Antigen Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Prostate Specific Antigen Sales by Manufacturers
      • 3.1.1 Prostate Specific Antigen Sales by Manufacturers
      • 3.1.2 Prostate Specific Antigen Sales Market Share by Manufacturers
      • 3.1.3 Global Prostate Specific Antigen Market Concentration Ratio (CR5 and HHI)
    • 3.2 Prostate Specific Antigen Revenue by Manufacturers
      • 3.2.1 Prostate Specific Antigen Revenue by Manufacturers (2014-2019)
      • 3.2.2 Prostate Specific Antigen Revenue Share by Manufacturers (2014-2019)
    • 3.3 Prostate Specific Antigen Price by Manufacturers
    • 3.4 Prostate Specific Antigen Manufacturing Base Distribution, Product Types
      • 3.4.1 Prostate Specific Antigen Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Prostate Specific Antigen Product Type
      • 3.4.3 Date of International Manufacturers Enter into Prostate Specific Antigen Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Prostate Specific Antigen Sales by Product
    • 4.2 Global Prostate Specific Antigen Revenue by Product
    • 4.3 Prostate Specific Antigen Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Prostate Specific Antigen Breakdown Data by End User

    6 North America

    • 6.1 North America Prostate Specific Antigen by Countries
      • 6.1.1 North America Prostate Specific Antigen Sales by Countries
      • 6.1.2 North America Prostate Specific Antigen Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Prostate Specific Antigen by Product
    • 6.3 North America Prostate Specific Antigen by End User

    7 Europe

    • 7.1 Europe Prostate Specific Antigen by Countries
      • 7.1.1 Europe Prostate Specific Antigen Sales by Countries
      • 7.1.2 Europe Prostate Specific Antigen Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Prostate Specific Antigen by Product
    • 7.3 Europe Prostate Specific Antigen by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Prostate Specific Antigen by Countries
      • 8.1.1 Asia Pacific Prostate Specific Antigen Sales by Countries
      • 8.1.2 Asia Pacific Prostate Specific Antigen Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Prostate Specific Antigen by Product
    • 8.3 Asia Pacific Prostate Specific Antigen by End User

    9 Central & South America

    • 9.1 Central & South America Prostate Specific Antigen by Countries
      • 9.1.1 Central & South America Prostate Specific Antigen Sales by Countries
      • 9.1.2 Central & South America Prostate Specific Antigen Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Prostate Specific Antigen by Product
    • 9.3 Central & South America Prostate Specific Antigen by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Prostate Specific Antigen by Countries
      • 10.1.1 Middle East and Africa Prostate Specific Antigen Sales by Countries
      • 10.1.2 Middle East and Africa Prostate Specific Antigen Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Prostate Specific Antigen by Product
    • 10.3 Middle East and Africa Prostate Specific Antigen by End User

    11 Company Profiles

    • 11.1 Advaxis, Inc.
      • 11.1.1 Advaxis, Inc. Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Advaxis, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Advaxis, Inc. Prostate Specific Antigen Products Offered
      • 11.1.5 Advaxis, Inc. Recent Development
    • 11.2 Aeterna Zentaris Inc.
      • 11.2.1 Aeterna Zentaris Inc. Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 Aeterna Zentaris Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 Aeterna Zentaris Inc. Prostate Specific Antigen Products Offered
      • 11.2.5 Aeterna Zentaris Inc. Recent Development
    • 11.3 Bavarian Nordic A/S
      • 11.3.1 Bavarian Nordic A/S Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Bavarian Nordic A/S Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Bavarian Nordic A/S Prostate Specific Antigen Products Offered
      • 11.3.5 Bavarian Nordic A/S Recent Development
    • 11.4 Curevac AG
      • 11.4.1 Curevac AG Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Curevac AG Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Curevac AG Prostate Specific Antigen Products Offered
      • 11.4.5 Curevac AG Recent Development
    • 11.5 GenSpera, Inc.
      • 11.5.1 GenSpera, Inc. Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 GenSpera, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 GenSpera, Inc. Prostate Specific Antigen Products Offered
      • 11.5.5 GenSpera, Inc. Recent Development
    • 11.6 Inovio Pharmaceuticals, Inc.
      • 11.6.1 Inovio Pharmaceuticals, Inc. Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Inovio Pharmaceuticals, Inc. Prostate Specific Antigen Products Offered
      • 11.6.5 Inovio Pharmaceuticals, Inc. Recent Development
    • 11.7 OncBioMune Pharmaceuticals Inc.
      • 11.7.1 OncBioMune Pharmaceuticals Inc. Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 OncBioMune Pharmaceuticals Inc. Prostate Specific Antigen Products Offered
      • 11.7.5 OncBioMune Pharmaceuticals Inc. Recent Development

    12 Future Forecast

    • 12.1 Prostate Specific Antigen Market Forecast by Regions
      • 12.1.1 Global Prostate Specific Antigen Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Prostate Specific Antigen Revenue Forecast by Regions 2019-2025
    • 12.2 Prostate Specific Antigen Market Forecast by Product
      • 12.2.1 Global Prostate Specific Antigen Sales Forecast by Product 2019-2025
      • 12.2.2 Global Prostate Specific Antigen Revenue Forecast by Product 2019-2025
    • 12.3 Prostate Specific Antigen Market Forecast by End User
    • 12.4 North America Prostate Specific Antigen Forecast
    • 12.5 Europe Prostate Specific Antigen Forecast
    • 12.6 Asia Pacific Prostate Specific Antigen Forecast
    • 12.7 Central & South America Prostate Specific Antigen Forecast
    • 12.8 Middle East and Africa Prostate Specific Antigen Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Prostate Specific Antigen Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      The global Prostate Specific Antigen market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Prostate Specific Antigen market based on company, product type, end user and key regions.

      This report studies the global market size of Prostate Specific Antigen in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prostate Specific Antigen in these regions.
      This research report categorizes the global Prostate Specific Antigen market by top players/brands, region, type and end user. This report also studies the global Prostate Specific Antigen market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Advaxis, Inc.
      Aeterna Zentaris Inc.
      Bavarian Nordic A/S
      Curevac AG
      GenSpera, Inc.
      Inovio Pharmaceuticals, Inc.
      OncBioMune Pharmaceuticals Inc.

      Market size by Product
      G-115
      INO-5150
      ADXS-PSA
      AEZS-120
      Others
      Market size by End User
      Prostate Cancer
      Metastatic Hormone Refractory Prostate Cancer
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Prostate Specific Antigen market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Prostate Specific Antigen market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Prostate Specific Antigen companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Prostate Specific Antigen submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Prostate Specific Antigen are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prostate Specific Antigen market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now